Search Results for: "Category: Scientific Communications"

For life science organizations, scientific, medical, and patient advocacy conferences are much more than dates on a calendar. They are opportunities to share data, engage with key opinion leaders (KOLs),…

In many pharmaceutical and biotechnology companies, publications and medical communications teams are no longer viewed as executional functions responsible solely for delivering manuscripts, congress presentations, and publication plans. They’re increasingly expected to be strategic partners. That…

Building a Scientific Platform is one of the most valuable activities in Medical Affairs, but it is rarely the easiest. The biggest challenges often don’t involve the science itself. They’re…

Every year, medical communications teams invest significant resources generating high-quality evidence through publications, congress presentations, advisory boards, and clinical research. Yet as that evidence is translated into HCP materials, field…

For pharmaceutical, biotech, and medical device organizations, every review delay can impact campaign timelines, product communications, and stakeholder engagement. The challenge isn’t just reviewing content. It’s doing so efficiently while…

Today’s scientific ecosystem is more interconnected than ever. Clinical development teams, Medical Affairs, investigators, regulators, advocacy organizations, publication professionals, and other stakeholders all contribute to advancing medical evidence. Yet even…

A publication plan isn’t something you create once and put on a shelf. As clinical milestones shift, data mature, stakeholder priorities evolve, and regional needs emerge, publication strategies must continuously…

Great science deserves to be understood. In today’s fast-paced medical communications environment, effective data visualization is essential for transforming complex findings into insights that resonate with diverse audiences. The right…

As healthcare stakeholders demand more comprehensive evidence to inform decisions, publication planning can no longer operate in isolation. Today’s value story is built from multiple evidence streams:🟦 Clinical trial data🟦…